Narayana Murty. Karri

Viral vaccines and CAR-T cell therapy process development and manufacturing expert.

Role: Assistant General Manager at Bharat Biotech
Location: Hyderabad, TG, IN
LinkedIn followers: 500 followers

OperationsView LinkedIn profile

About Narayana Murty. Karri

Over 20 years of extensive experience in process development and manufacturing of viral…

Experience

Assistant General Manager
Bharat Biotech
Jun 2025 — Present · Hyderabad, IN
Research and Development

Education

Andhra University
Bachelor of Science (B.Sc), Biochemistry; Biotechnology and Microbiology
2000 — 2003
Andhra University
Master’s Degree, Biochemistry
2003 — 2005

Skills

Validation
Immunofluorescence Asssay
Cell Lines
Glp
Mammalian Cell Culture
Vaccines
Handling of Diffrent Cell Lines and Viruses
Cell
Cgmp Manufacturing
Sop
Plaque Assay

Contact information

Verified work emails, personal emails, and direct dials — unlocked in one click.

Work email
•••••@bharatbiotech.com
Personal email
•••••@•••••.com
Direct dial
+•• ••• ••• ••••

Unlock verified contacts

Free to start · No credit card required

Current company

Bharat Biotech

Biotechnology · 2K employees · Founded 1996 · Hyderabad, Telangana, India

Bharat Biotech International Limited is a multidimensional biotechnology company specializing in product-oriented research and development leading to the manufacture of vaccines and bio-therapeutics in Hyderabad, India. Bharat Biotech was established in the year 1996 by Dr. Krishna M. Ella and Mrs. Suchitra K. Ella. Bharat Biotech is a pioneering biotechnology company known for its world-class R&D and manufacturing capabilities. Our mission is to deliver affordable, safe and high-quality vaccines and bio-therapeutics that help people prevail over diseases. We seek to lead innovation in biotechnology in order to lead the fight against disease with a focus on emerging markets. Our significant R&D investments have yielded several breakthroughs including the world’s 1st Eco-friendly recombinant Hepatitis-B vaccine (free of cesium chloride and Thiomersal).Rotavirus vaccine from a naturally attenuated strain,Typhoid Conjugate vaccine. Transparency and openness are central to our DNA. An uncompromising commitment to integrity differentiates us. Our clinical trials are known for their rigor and breadth. We also adopt the most comprehensive data integrity procedures to ensure that we capture, store and report data accurately. We are committed to provide affordable and innovative vaccines for healthier lives. Bharat Biotech launched India’s first recombinant Epidermal Growth Factor (REGEN-D®) to combat diabetic foot ulcers, burns. Typbar TCV® is the world’s first clinically proven conjugate Typhoid vaccine and received WHO-Prequalification in January 2018. ROTAVAC® was India’s first and largest efficacy clinical trial on vaccines and Rotavac® received WHO-Prequalification in January 2018. Bharat Biotech Launches ROTAVAC 5D®- Lowest dose volume Rotavirus vaccine - ROTAVAC in the world launched in December 2019. COVAXIN, India\'s indigenous COVID-19 vaccine by Bharat Biotech.

bharatbiotech.com

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Start for free See how it works

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.